Critical Recall
On September 17, 2026, the Therapeutic Goods Administration (TGA) removed Andrographis paniculata (Andrographis) from the list of ingredients permitted for use in listed medicines in Australia following a review of its safety. This follows a safety review into the potential for severe allergic reactions, including anaphylaxis.
Swisse Wellness Pty Ltd, following agreement with the Therapeutic Goods Administration, is performing a recall for all batches within the expiry of the listed medicines Swisse Nutra+ Andro Max 30 tabs and Swisse Ultiboost Immune Action 60 tabs. These products contain the herb Andrographis paniculata (Andrographis), which is associated with reports of rare but serious allergic reactions including anaphylaxis.
Anaphylaxis is the most severe type of allergic reaction and is a medical emergency. An anaphylactic reaction requires immediate treatment with adrenaline (epinephrine).
Delayed treatment can be life threatening. Anyone who is concerned in any way about the use of these products should consult their health care provider.
All batches within expiry of the listed medicines below
Swisse Nutra+ Andro Max 30 Tabs
AUST L/ARTG 330145
Swisse Ultiboost Immune Action 60 Tabs
AUST L/ARTG 326345
Risks
These products contain the herb Andrographis paniculata (Andrographis), which is associated with reports of rare but serious allergic reactions including anaphylaxis.
What To Do Next
If you have any of the affected products listed above, please stop using the product and get in touch with our Customer Care team.
We’re here to help and can arrange the return of your affected product and organise a refund for you.
CUSTOMER CARE | 1800 794 773 | recall@swisse.com.au